SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (6013)1/27/1999 11:58:00 PM
From: Vector1  Read Replies (1) of 6136
 
Rick,
They are state of the art protections for a buyer of a public company. General rule is a breakup fee of no more than 2.5% of the total valuation. The option on 19.9% is a bit more controversial and could concievably be thrown our by a court, but you would need a very motivated third party bidder. Very unkikely since Dupont blinked at the price WLA is paying. this a very good deal for everyone and will be a steal for WLA if Remune surprises.
For those of us with large short term gains in the stock, the tax free nature of the deal is appreciated

V1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News